Impel Pharmaceuticals Inc. ( IMPL) - Stock Earnings

IMPL Quarterly earnings

DateEarningsRevenue
2022Q2 -25.2 million USD 2.8 million USD
2022Q3 -31.1 million USD 3.1 million USD
2022Q4 -23.0 million USD 5.0 million USD

IMPL Yearly earnings

DateEarningsRevenue
2020 -45.8 million USD 0 USD
2021 -76.5 million USD 668000 USD
2022 -106.3 million USD 12.7 million USD

IMPL

Price: $0.04

52 week price:
0.04
4.20

Earnings Per Share: -0.87 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 23000

Market Capitalization: 8.8 million

Links: